Socionext (6526) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
28 Oct, 2026Executive summary
Q2 FY2027 sales rose 14.7% YoY to ¥60.4bn; H1 sales increased 14.0% to ¥99.423bn, while H1 operating income fell 55.7% to ¥1.668bn and net profit declined 25.9% to ¥1.526bn.
FY2027 guidance was raised to ¥225bn sales, ¥15.5bn operating income and ¥10.5bn net profit; the annual dividend forecast remains ¥50 per share.
Financial highlights
Q2 product revenue was ¥50.2bn (+12.8% YoY) and NRE revenue ¥10.2bn (+28.4%); operating income was ¥2.3bn and net income ¥2.1bn.
H1 product revenue grew 10.2% to ¥77.551bn and NRE revenue 32.9% to ¥21.827bn, mainly on data center and networking growth.
H1 gross profit rose 7.8% to ¥45.191bn; cost of sales increased 19.8% to ¥54.232bn and SG&A rose 14.0% to ¥43.523bn.
H1 ordinary income declined 19.8% to ¥2.240bn; comprehensive income was ¥1.406bn.
Outlook and guidance
Revised FY2027 forecast: sales ¥225bn, operating and ordinary income ¥15.5bn, and net profit ¥10.5bn; basic EPS is ¥59.86.
Versus prior guidance, sales increased ¥10bn, operating and ordinary income ¥1.5bn, and net profit ¥0.5bn, partly reflecting weaker-than-assumed H1 yen rates.
H2 forecast assumes ¥130/$; full-scale shipments of North American data center and automotive products are scheduled from H2 FY2027 and thereafter.
Annual dividend forecast remains ¥50 per share, comprising ¥25 interim and ¥25 year-end.
From FY2028, sales are expected to exceed Medium-Term Target assumptions; revenue growth is expected to offset lower product gross margin and improve operating income through leverage.
Latest events from Socionext
- FY24 growth was strong, but special-demand roll-off weighs on FY25 guidance.6526
Q4 2024 - Net sales rose 13% YoY, but higher costs led to operating and net losses.6526
Q1 2027 - Net sales up 6.5% YoY, but profit fell; FY27 outlook expects renewed growth.6526
Q4 2026 - Sales rebounded, but profits and margins remain pressured by costs and FX; guidance unchanged.6526
Q3 2026 - Sales guidance raised but profit outlook cut as margins shrink amid higher costs and weak demand.6526
Q2 2026 - Sharp profit and sales drop in 1Q FY26/3, but full-year guidance and recovery outlook are maintained.6526
Q1 2026 - Sales and profit fell, but R&D and NRE revenue rose; treasury stock buyback approved.6526
Q2 2025 - Net sales fell 14.1% but operating income and R&D investment both increased.6526
Q1 2025 - Revenue and profit fell sharply, but investments and design wins support future growth.6526
Q4 2025